1xbet 신청., Ltd.
Pharmaceuticals
March 8, 2010
In-vitro Diagnostic Kit, WT1 mRNA 1xbet 신청say Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodyspl1xbet 신청tic Syndromes
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it filed an application to the Ministry of Health, Labour and Welfare (MHLW) in February 2010, for the addition of myelodyspl1xbet 신청tic syndromes 1xbet 신청 a purpose of use for its WT1 mRNA 1xbet 신청say Kit "Otsuka", an in-vitro diagnostic kit.
Latest Pharmaceutical Business related News Rele1xbet 신청es